- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The Great Debate at “Melanoma Bridge”, Napoli, December 2nd, 2017 ; volume:16 ; number:1 ; day:17 ; month:4 ; year:2018 ; pages:1-12 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (17.4.2018), 1-12, 12.2018
- Urheber
-
Ascierto, Paolo A.
- Beteiligte Personen und Organisationen
-
Caracò, Corrado
Gershenwald, Jeffrey E.
Hamid, Omid
Ross, Merrick
Sullivan, Ryan J.
Puzanov, Igor
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1477-8
- URN
-
urn:nbn:de:101:1-2018062122530381661307
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ascierto, Paolo A.
- Caracò, Corrado
- Gershenwald, Jeffrey E.
- Hamid, Omid
- Ross, Merrick
- Sullivan, Ryan J.
- Puzanov, Igor
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Melanoma: A model for testing new agents in combination therapies
The “Great Debate” at Melanoma Bridge 2021, December 2nd–4th, 2021
What have we learned from cancer immunotherapy in the last 3 years?
Combination therapy: the next opportunity and challenge of medicine
World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016
The “Great Debate” at Immunotherapy Bridge 2021, December 1st–2nd, 2021
The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application